More Atomo Diagnostics Ltd. news
Atomo Diagnostics Ltd.ASX: AT1

Atomo & Access Bio enter North American COVID-19 partnership

Jul 28, 2020 at 3:51 AM EDT · Issued by Atomo Diagnostics Ltd.

Filed with ASX · Jul 28, 2020 at 3:51 AM EDT

On 6ix: 6ix.com/news/atomo-and-access-bio-enter-north-american-covid-19-partnership

Atomo Diagnostics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Atomo Diagnostics Ltd. on 6ix

In the deck

  • Atomo Diagnostics — Investor Presentation (July 2020)12 slidesJul 29, 2020

Earlier from Atomo Diagnostics

  • Quarterly Activity Report & Appendix 4C - 30 June 2020Jul 22, 2020
  • S&P DJI Announces June 2020 Quarterly RebalanceJun 11, 2020
  • Atomo and NG Biotech expand COVID-19 partnershipJun 4, 2020
  • Atomo receives additional order for COVID19 test devicesMay 7, 2020

Later from Atomo Diagnostics

  • Atomo receives TGA approval for COVID19 antibody testAug 10, 2020
  • FY20 Results PresentationAug 30, 2020
  • DIVOC Labs to sell Atomos COVID-19 test in IndiaSep 23, 2020
  • Atomo & Access Bio sign deal for rapid antigen testSep 29, 2020
  • Atomo receives TGA approval for COVID19 antigen testOct 27, 2020
All Atomo Diagnostics news releases↗

Follow Atomo Diagnostics into a list and get an email when it puts out news.

Follow Atomo Diagnostics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer